Immediate Impact

56 standout
Sub-graph 1 of 23

Citing Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
2024 Standout
2 intermediate papers

Works of Jenna E. Coalson being referenced

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
2017
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
2016

Author Peers

Author Last Decade Papers Cites
Jenna E. Coalson 384 118 101 275 127 26 822
Martin De Smet 371 105 82 140 31 27 839
Gasim I Gasim 164 133 130 90 246 41 878
Wolmar Pulcheri 84 43 146 158 234 40 803
B. S. Kaplan 72 153 35 102 95 38 899
Elizabeth V. Potter 239 21 17 132 100 31 655
Anette Tarp Hansen 62 75 205 135 89 44 886
A. F. Fleming 333 102 99 261 51 39 846
A Duboust 133 43 50 90 102 45 743
Michal Solomon 392 24 53 91 209 42 904
Sven Klaesson 145 54 14 494 177 26 771

All Works

Loading papers...

Rankless by CCL
2026